|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,144.00 INR | +0.89% |
|
+3.13% | -2.39% |
| 19/03 | Novo Nordisk patent expiry opens door to cheaper weight-loss drugs in India | RE |
| 18/03 | Mankind Pharma buys Rivotril brand from Roche for India | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.89% | +3.13% | +7.16% | +1.27% | -2.39% | -16.95% | - | - | - | 948.06Cr | |
| -0.03% | -0.37% | +2.14% | -11.06% | -13.82% | +13.22% | +147.10% | +385.88% | +1,101.53% | 83TCr | |
| -0.84% | -2.37% | -1.30% | +6.46% | +12.25% | +48.04% | +42.02% | +39.54% | +104.53% | 56TCr | |
| -1.55% | -0.71% | -0.03% | -4.22% | -10.28% | +20.48% | +26.75% | +88.03% | +238.97% | 37TCr | |
| -0.41% | +1.39% | +4.68% | -7.73% | -2.50% | +25.20% | +16.28% | +3.13% | +25.79% | 33TCr | |
| -1.10% | -0.24% | +7.60% | +10.59% | +8.43% | +47.46% | +24.50% | +99.52% | +261.07% | 32TCr | |
| -0.99% | -1.79% | +3.35% | +7.82% | +12.11% | +51.58% | +3.36% | +50.19% | +108.56% | 29TCr | |
| -0.50% | -1.99% | +2.27% | +3.47% | +7.86% | +30.37% | +34.11% | +47.13% | +59.65% | 29TCr | |
| -0.81% | +0.78% | +1.36% | +6.51% | +7.71% | +28.81% | +44.80% | +36.04% | +116.60% | 19TCr | |
| -0.96% | +8.25% | +8.61% | -33.79% | -20.71% | -33.87% | -53.88% | +14.62% | +38.51% | 18TCr | |
| -0.64% | -1.67% | -0.37% | +10.12% | +11.38% | +31.03% | +61.42% | +105.94% | +36.56% | 17TCr | |
| +0.38% | +1.22% | +2.61% | +8.44% | +11.14% | +25.56% | -30.55% | -29.10% | -16.72% | 16TCr | |
| -1.27% | +2.42% | +3.45% | +9.67% | +10.24% | +21.51% | -14.48% | -10.01% | -14.11% | 12TCr | |
| +0.01% | +3.30% | +5.45% | +5.13% | -0.83% | -10.02% | -19.18% | -4.68% | +5.19% | 12TCr | |
| 0.00% | -1.20% | +9.92% | +19.41% | +17.51% | +57.42% | +45.77% | +29.43% | +14.69% | 12TCr | |
| -0.41% | -0.08% | -3.15% | -0.54% | -3.01% | -7.92% | +33.59% | +99.72% | +422.77% | 11TCr | |
| +5.93% | +1.95% | +2.24% | +7.49% | +7.29% | +6.20% | +166.47% | +106.25% | +640.08% | 8.69TCr | |
| -0.20% | -2.74% | -3.35% | +9.19% | +15.31% | +30.01% | +24.50% | +50.43% | +4.77% | 5.58TCr | |
| +0.02% | -1.26% | +0.57% | -7.82% | -5.42% | +17.38% | +15.78% | -17.64% | +281.44% | 5.48TCr | |
| +0.63% | +1.40% | +7.75% | -3.62% | +11.75% | +92.51% | -32.19% | -23.61% | -62.30% | 4.77TCr | |
| Average | -0.10% | +0.35% | +3.05% | +1.84% | +3.70% | +23.90% | +28.22% | +56.36% | +177.24% | 22.09TCr | |
| Weighted average by Cap. | -0.46% | -0.24% | +2.52% | -0.06% | +1.21% | +26.32% | +46.35% | +109.31% | +306.44% |
- Stock Market
- Equities
- MANKIND Stock
- Sector Mankind Pharma Limited
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition